Urinary matrix metalloproteinase activity is not significantly altered in patients with renal cell carcinoma

Glenn M Cannon1, Robert H Getzenberg

  • 1Department of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania 15213-3232, USA. cannongm@upmc.edu

Urology
|March 29, 2006
PubMed
Abstract

Insights

Urinary matrix metalloproteinase (MMP) activity, measured by collagen IV degradation, did not prove effective in diagnosing renal cell carcinoma (RCC). Most healthy individuals exhibited significant MMP activity, limiting its diagnostic utility for this cancer.

Area of Science:

  • Biochemistry
  • Oncology
  • Urology

Background:

  • Matrix metalloproteinases (MMPs) are enzymes involved in extracellular matrix degradation.
  • Elevated MMPs in urine have been suggested as a potential biomarker for various cancers, including renal cell carcinoma (RCC).
  • Collagen IV degradation by MMPs is a key process in tumor invasion and metastasis.

Purpose of the Study:

  • To evaluate the diagnostic utility of urinary matrix metalloproteinase (MMP) activity for identifying renal cell carcinoma (RCC).
  • To confirm if a fluorescent microplate activity assay measuring collagen IV degradation can serve as a diagnostic test for RCC.

Main Methods:

  • Urine samples were collected from 21 patients with renal masses, 2 patients with suspected RCC recurrence, and 47 healthy volunteers.
  • Urine samples were incubated with fluorescein-labeled collagen IV.
  • Fluorescence activity was measured to quantify collagen IV degradation, indicating MMP activity.

Main Results:

  • Fifteen of 21 patients undergoing nephrectomy had RCC; both patients with retroperitoneal mass excision had confirmed RCC recurrence.
  • Mean fluorescence units in RCC patients were 48,924 (range 0–275,879) versus 29,834 (range 0–400,086) in healthy individuals.
  • The difference in MMP activity between RCC patients and healthy volunteers was not statistically significant (P = 0.34).

Conclusions:

  • Urinary MMP activity, as measured by collagen IV degradation, is not a reliable diagnostic test for identifying RCC.
  • Significant MMP activity was observed in the urine of most healthy individuals, confounding its use as a specific cancer biomarker.
  • Further research may be needed to explore other biomarkers or refine existing assays for RCC detection.

Related Concept Videos

Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
Urinary Tract Calculi V: Nursing Management01:28

Urinary Tract Calculi V: Nursing Management

AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...